SHELLEY MILLER: Open Payments
NPI 1790793594 · LEBANON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$348 in 17 payments from 9 companies in 2025. Trend: 2023 $497 · 2024 $504 · 2025 $348
Food & beverage: $348
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $89 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Dexcom, Inc. | 1 | $34 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| PFIZER INC. | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
Products named: MOUNJARO, JARDIANCE, FARXIGA, TRELEGY ELLIPTA, Dexcom G6 Transmitter, Auvelity, TRINTELLIX, BREZTRI.
Industry payments across VA — which companies pay providers there.
